Melanomas

2 clinical trials · Condition

Record	Firm	Date
Aerosolized Azacytidine as Epigenetic Priming for Bintrafusp Alfa-Mediated Immune Checkpoint Blockade in Patients With Unresectable Pulmonary Metastases From Sarcomas, Germ Cell Tumors, or Epithelial Malignancies (NCT04648826)	National Cancer Institute (NCI)	2021-12-14

Every clearance here is in the API, with alerts when new ones post.